Abstract:AIM:To study the influence of inducers of drug metabolism enzyme, beta-naphthoflavone (BNF) and dexamethasone (DEX), on the stereoselective metabolism of propafenone in the rat hepatic microsomes.METHODS:Phase I metabolism of propafenone was studied using the microsomes induced by BNF and DEX and the non-induced microsome was used as the control. The enzymatic kinetics parameters of propafenone enantiomers were calculated by regress analysis of Eadie-Hofstee Plots. Propafenone enantiomer concentrations were assayed by a chiral HPLC.RESULTS:The metabolite of propafenone, N-desalkylpropafenone, was found after incubation of propafenone with the rat hepatic microsomes induced by BNF and DEX. In these two groups, the stereoselectivity favoring R(-) isomer was observed in metabolism at low substrate concentrations of racemic propafenone, but lost the stereoselectivity at high substrate concentrations. However, in control group, no stereoselectivity was observed. The enzyme kinetic parameters were: (1) K(m).CONTROL GROUP:R(-) 83+/-6, S(+) 94+/-7; BNF group: R(-) 105+/-6, S(+)128+/-14; DEX group: R(-) 86+/-11, S(+) 118+/-16; (2)V(max).CONTROL GROUP:R(-) 0.75+/-0.16, S(+) 0.72+/-0.07; BNF group: R(-) 1.04+/-0.15, S(+)1.07+/-14; DEX group: R(-) 0.93+/-0.06, S(+) 1.04+/-0.09; (3)Cl(int).CONTROL GROUP:R(-) 8.9+/-1.1, S(+) 7.6+/-0.7; BNF group: R(-) 9.9+/-0.9, S(+)8.3+/-0.7; DEX group: R(-) 10.9+/-0.8, S(+) 8.9+/-0.9. The enantiomeric differences in K(m) and Cl(int) were both significant, but not in V(max), in BNF and DEX group. Whereas enantiomeric differences in three parameters were all insignificant in control group. Furthermore, K(m) and V(max) were both significantly less than those in BNF or DEX group. In the rat liver microsome induced by DEX, nimodipine (NDP) decreased the stereoselectivity in propafenone metabolism at low substrate concentration. The inhibition of NDP on the metabolism of propafenone was stereoselective with R(-)-isomer being impaired more than S(+)-isomer. The inhibition constant (Ki) of S(+)- and R(-)-propafenone, calculated from Dixon plots, was 15.4 and 8.6 mg x L(-1), respectively.CONCLUSION:CYP1A subfamily(induced by BNF) and CYP3A4 (induced by DEX) have pronounced contribution to propafenone N-desalkylation which exhibited stereoselectivity depending on substrate concentration. The molecular base for this phenomenon is the stereoselectivity in affinity of substrate to the enzyme activity centers instead of at the catalyzing sites.

Enzyme Kinetics and Inhibition of Nimodipine Metabolism in Human Liver Microsomes

Metabolism and Metabolic Inhibition of Cilnidipine in Human Liver Microsomes.

Induction of Diphenytriazol on Cytochrome CYP1A.

Elucidation on inhibition and binding mechanism of bovine liver catalase by nifedipine: multispectroscopic analysis and computer simulation methods

Chiral Metabolism of Propafenone in Rat Hepatic Microsomes Treated with Two Inducers

Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system

The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6

Effect of P-glycoprotein Inhibitors Erythromycin and Cyclosporin A on Brain Pharmacokinetics of Nimodipine in Rats

[Metabolism of nicousamide in rat and human liver in vitro]

Study on Pharmacokinetics and Bioavailability of Nimodipine Nanostructured Lipid Carrier in Rats

Functional Evaluation of Cyclosporine Metabolism by CYP3A4 Variants and Potential Drug Interactions.

The Variability in CYP3A4 Activity Determines the Metabolic Kinetic Characteristics of Ketamine.

The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline

Metabolic Activation and Cytotoxicity of Donepezil Induced by CYP3A4

Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans

Function of 38 Variants CYP2C9 Polymorphism on Ketamine Metabolism in Vitro

Enzyme kinetics of novel antiepileptic drug 3,4-dichlorophenyl-propenoyl-sec.-butylamine in rat liver microsomes in vitro

Clomipramine N-Demethylation Metabolism in Human Liver Microsomes

In vitro metabolism of indiplon and an assessment of its drug interaction potential

Characterization of Nuciferine Metabolism by P450 Enzymes and Uridine Diphosphate Glucuronosyltransferases in Liver Microsomes from Humans and Animals

Enzyme Kinetics Research of Propofol in Human Liver Microsomes